Kyowa Kirin Co., Ltd.
Overview
Kyowa Kirin Co., Ltd. is a leading Japanese pharmaceutical company focused on creating new drugs that address unmet medical needs. It is a subsidiary of Kyowa Hakko Kirin Holdings Co., Ltd. and specializes in therapeutic areas such as oncology, nephrology, and immunology.
Core services & business areas
Therapeutic areas
Active pharmaceutical ingredients supplied
Substances Kyowa Kirin Co., Ltd. is evidenced to supply (US FDA Drug Master File or EU CEP). Open any ingredient to see its full supplier landscape, CAS number and patent status.
API / Drug Master Files
Kyowa Kirin Co., Ltd. holds 0 active (3 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.
- KW-6356 DRUG SUBSTANCEInactive2014-11-06
- ASKP1240 MONOCLONAL ANTIBODY DRUG SUBSTANCE AND DRUG PRODUCTInactive2008-05-08
- OLOPATADINE HYDROCHLORIDE (KW 4679)Inactive1996-01-10
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Kyowa Kirin Co., Ltd. in our records. PharmaTek screens the full directory against live FDA enforcement data.
Is this Kyowa Kirin Co., Ltd.? Get in front of buyers actively sourcing.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.